Amelogenin dosage compensation in carcinoma of colon, lung, liver and kidney, is not a marker of clonality in males. (Q50867957)
Jump to navigation
Jump to search
scientific article published in August 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Amelogenin dosage compensation in carcinoma of colon, lung, liver and kidney, is not a marker of clonality in males. |
scientific article published in August 1998 |
Statements
Amelogenin dosage compensation in carcinoma of colon, lung, liver and kidney, is not a marker of clonality in males. (English)
1 reference
Zvejnieks PA
1 reference
Tellschow SR
1 reference
Gudlaugsson EG
1 reference
Markham N
1 reference
Shroyer KR
1 reference
1 August 1998
1 reference
12
1 reference
4
1 reference
185-190
1 reference